Logo image of AXGN

AXOGEN INC (AXGN) Stock Fundamental Analysis

USA - NASDAQ:AXGN - US05463X1063 - Common Stock

17.92 USD
-0.25 (-1.38%)
Last: 10/27/2025, 1:41:09 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AXGN. AXGN was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AXGN get a neutral evaluation. Nothing too spectacular is happening here. AXGN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AXGN had positive earnings in the past year.
AXGN had a positive operating cash flow in the past year.
AXGN had negative earnings in each of the past 5 years.
AXGN had negative operating cash flow in 4 of the past 5 years.
AXGN Yearly Net Income VS EBIT VS OCF VS FCFAXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

With a decent Return On Assets value of -2.27%, AXGN is doing good in the industry, outperforming 68.25% of the companies in the same industry.
AXGN has a Return On Equity of -4.15%. This is in the better half of the industry: AXGN outperforms 69.84% of its industry peers.
The Return On Invested Capital of AXGN (0.75%) is better than 66.67% of its industry peers.
Industry RankSector Rank
ROA -2.27%
ROE -4.15%
ROIC 0.75%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
AXGN Yearly ROA, ROE, ROICAXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With a decent Operating Margin value of 0.84%, AXGN is doing good in the industry, outperforming 66.14% of the companies in the same industry.
The Gross Margin of AXGN (74.27%) is better than 85.71% of its industry peers.
AXGN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.84%
PM (TTM) N/A
GM 74.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
AXGN Yearly Profit, Operating, Gross MarginsAXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

AXGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AXGN has more shares outstanding
Compared to 5 years ago, AXGN has more shares outstanding
The debt/assets ratio for AXGN has been reduced compared to a year ago.
AXGN Yearly Shares OutstandingAXGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXGN Yearly Total Debt VS Total AssetsAXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

AXGN has an Altman-Z score of 4.85. This indicates that AXGN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AXGN (4.85) is better than 77.78% of its industry peers.
AXGN has a debt to FCF ratio of 13.85. This is a negative value and a sign of low solvency as AXGN would need 13.85 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.85, AXGN is in the better half of the industry, outperforming 71.96% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that AXGN is not too dependend on debt financing.
AXGN has a Debt to Equity ratio (0.43) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 13.85
Altman-Z 4.85
ROIC/WACC0.08
WACC8.85%
AXGN Yearly LT Debt VS Equity VS FCFAXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 4.14 indicates that AXGN has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.14, AXGN is doing good in the industry, outperforming 71.43% of the companies in the same industry.
AXGN has a Quick Ratio of 2.67. This indicates that AXGN is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.67, AXGN is doing good in the industry, outperforming 64.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 2.67
AXGN Yearly Current Assets VS Current LiabilitesAXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 500.00% over the past year.
The Revenue has grown by 17.17% in the past year. This is quite good.
AXGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.92% yearly.
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)17.17%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%18.26%

3.2 Future

The Earnings Per Share is expected to grow by 50.38% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 16.23% on average over the next years. This is quite good.
EPS Next Y110.54%
EPS Next 2Y93.39%
EPS Next 3Y90.78%
EPS Next 5Y50.38%
Revenue Next Year17.82%
Revenue Next 2Y16.82%
Revenue Next 3Y15.02%
Revenue Next 5Y16.23%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AXGN Yearly Revenue VS EstimatesAXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
AXGN Yearly EPS VS EstimatesAXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 74.67 indicates a quite expensive valuation of AXGN.
AXGN's Price/Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 66.14% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.89, AXGN is valued quite expensively.
A Price/Forward Earnings ratio of 36.86 indicates a quite expensive valuation of AXGN.
AXGN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 70.90% of the companies in the same industry.
AXGN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 74.67
Fwd PE 36.86
AXGN Price Earnings VS Forward Price EarningsAXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

63.49% of the companies in the same industry are more expensive than AXGN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXGN indicates a somewhat cheap valuation: AXGN is cheaper than 68.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 237.95
EV/EBITDA 90.83
AXGN Per share dataAXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AXGN's earnings are expected to grow with 90.78% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y93.39%
EPS Next 3Y90.78%

0

5. Dividend

5.1 Amount

AXGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXOGEN INC

NASDAQ:AXGN (10/27/2025, 1:41:09 PM)

17.92

-0.25 (-1.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners88.49%
Inst Owner Change0.85%
Ins Owners0.84%
Ins Owner Change-0.61%
Market Cap824.50M
Revenue(TTM)203.27M
Net Income(TTM)-4663000
Analysts84
Price Target25.37 (41.57%)
Short Float %5.65%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-68.39%
Min EPS beat(2)-222.55%
Max EPS beat(2)85.77%
EPS beat(4)3
Avg EPS beat(4)275.79%
Min EPS beat(4)-222.55%
Max EPS beat(4)1125.49%
EPS beat(8)7
Avg EPS beat(8)185.94%
EPS beat(12)11
Avg EPS beat(12)146.94%
EPS beat(16)14
Avg EPS beat(16)116.93%
Revenue beat(2)1
Avg Revenue beat(2)2%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)5.47%
Revenue beat(4)2
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)1.38%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)7
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)2.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.39%
EPS NY rev (1m)0%
EPS NY rev (3m)28.8%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 74.67
Fwd PE 36.86
P/S 4.06
P/FCF 237.95
P/OCF 114.72
P/B 7.34
P/tB 7.77
EV/EBITDA 90.83
EPS(TTM)0.24
EY1.34%
EPS(NY)0.49
Fwd EY2.71%
FCF(TTM)0.08
FCFY0.42%
OCF(TTM)0.16
OCFY0.87%
SpS4.42
BVpS2.44
TBVpS2.31
PEG (NY)0.68
PEG (5Y)N/A
Graham Number3.63
Profitability
Industry RankSector Rank
ROA -2.27%
ROE -4.15%
ROCE 0.95%
ROIC 0.75%
ROICexc 0.9%
ROICexgc 0.94%
OM 0.84%
PM (TTM) N/A
GM 74.27%
FCFM 1.7%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 13.85
Debt/EBITDA 5.16
Cap/Depr 49.09%
Cap/Sales 1.83%
Interest Coverage 0.24
Cash Conversion 77.33%
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 2.67
Altman-Z 4.85
F-Score6
WACC8.85%
ROIC/WACC0.08
Cap/Depr(3y)337.29%
Cap/Depr(5y)669.18%
Cap/Sales(3y)9.04%
Cap/Sales(5y)13.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y110.54%
EPS Next 2Y93.39%
EPS Next 3Y90.78%
EPS Next 5Y50.38%
Revenue 1Y (TTM)17.17%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%18.26%
Revenue Next Year17.82%
Revenue Next 2Y16.82%
Revenue Next 3Y15.02%
Revenue Next 5Y16.23%
EBIT growth 1Y114.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1546.15%
EBIT Next 3Y209.77%
EBIT Next 5YN/A
FCF growth 1Y112.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y211.25%
OCF growth 3YN/A
OCF growth 5YN/A

AXOGEN INC / AXGN FAQ

What is the fundamental rating for AXGN stock?

ChartMill assigns a fundamental rating of 5 / 10 to AXGN.


What is the valuation status of AXOGEN INC (AXGN) stock?

ChartMill assigns a valuation rating of 5 / 10 to AXOGEN INC (AXGN). This can be considered as Fairly Valued.


How profitable is AXOGEN INC (AXGN) stock?

AXOGEN INC (AXGN) has a profitability rating of 4 / 10.


Can you provide the financial health for AXGN stock?

The financial health rating of AXOGEN INC (AXGN) is 6 / 10.


Can you provide the expected EPS growth for AXGN stock?

The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 110.54% in the next year.